Common use of Research Program Costs Clause in Contracts

Research Program Costs. Within five (5) days of the Effective Date, Ambrx will pay to Institute an amount equal to [***] as payment in advance for Institute’s activities pursuant to Approved Research Plans in the first partial calendar quarter following the Effective Date. Thereafter during the Research Program Term, Ambrx will make quarterly payments in advance to Institute of [***] ([***]) on or before each October 1, January 1, April 1 and July 1 that occurs during the Research Program Term in consideration of Institute’s activities pursuant to Approved Research Plans (each a “Research Funding Payment”); provided, however, the last payment made pursuant to this Section 7.1 shall be pro-rated to take into account the number of days in the last partial calendar quarter included in the Research Program Term.

Appears in 2 contracts

Sources: Collaborative License Agreement (Ambrx Biopharma Inc.), Collaborative License Agreement (Ambrx Biopharma Inc.)